Dystrophinopathies are a group of neuromuscular disorders, inherited in an X-linked recessive manner, caused by pathogenic variants in the DMD gene. Copy number variation detection and next generation sequencing allow the detection of around 99 % of the pathogenic variants. However, some patients require mRNA studies from muscle biopsies to identify deep intronic pathogenic variants. Here, we report a child suspected of having Duchenne muscular dystrophy, with a muscle biopsy showing dystrophin deficiency, and negative molecular testing for deletions, duplications, and small variants. mRNA analysis from muscle biopsy revealed a pseudoexon activation that introduce a premature stop codon into the reading frame. gDNA sequencing allowed to identified a novel variant, c.832-186 T>G, which creates a cryptic donor splice site, recognizing the underlying mechanism causing the pseudoexon insertion. This case highlights the usefulness of the mRNA analysis from muscle biopsy when routine genetic testing is negative and clinical suspicion of dystrophinopathies remains the main clinical diagnosis suspicion.
Keyphrases
- circulating tumor cells
- copy number
- duchenne muscular dystrophy
- mitochondrial dna
- genome wide
- muscular dystrophy
- skeletal muscle
- ultrasound guided
- dna methylation
- end stage renal disease
- fine needle aspiration
- chronic kidney disease
- ejection fraction
- newly diagnosed
- mental health
- binding protein
- gene expression
- real time pcr
- prognostic factors
- intellectual disability
- quantum dots